SIU School of Medicine

Jump directly to a section:

Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Complicated Skin Infections

IRB Number

12-271 Identifier


Trial Status

Open for Enrollment
Phase Post Market

Why is this study being done?

To learn more about the safety and how the study drug known as ceftaroline fosamil works in children.

Who is eligible to participate?

Children ages 2 months to less than 18 years old who have a skin infection requiring antibiotics in the hospital.

What is involved?

Participants will have a physical examination, be asked about medical history and current medications, and blood samples will be taken. Participants will receive IV antibiotics for the first 3 days in the hospital. On day 4 the study doctor will decide if the participant can leave the hospital, continue IV study treatment or switch to oral antibiotics.

How long is the study?

Participation will be at least 26 days and up to 50 days. Study treatment will be given for 5 to 14 days.

Who can I contact for additional information?

Please contact Kristal Adams, BA, CCRP, at (217) 545-7812 or email

Who is the Principal Investigator of this study?

Subhash Chaudhary, MD

Where is the trial located?

Springfield, Illinois